Accepting PhD Students

PhD projects

Please contact to discuss potential PhD projects in the fields of glucocorticoid biology, inflammation and neuroendocrinology

Personal profile

Biography

My lab harnesses the power of pre-clinical models of obesity and glucocorticoid-induced cardiometabolic dysregulation, together with translational approaches in humans, to better understand the underlying pathologies of cardiometabolic complications and to seek out better therapeutic approaches. Our lab has a specific interest type 2 diabetes, hypertension, atherosclerosis, and cardiac remodelling.

I obtained my undergraduate degree in Immunology from the University of Edinburgh, including a placement in the lab of Prof Ian Dransfield in the Centre for Inflammation Research, before undertaking a PhD at the Centre for Cardiovascular Science with Prof Ruth Andrew examining the role of glucocorticoid metabolism on inflammation. In 2012, I moved to the Integrative Biology and Pharmacology Department at the University of Texas Health Science Center Houston to continue my Postdoctoral training with Prof Rebecca Berdeaux. Here I identified a novel role for the AMPK-related kinase SIK1 in regulating glucose homeostasis in obesity.

In 2014, I joined Prof Brian Walker’s group at the Centre for Cardiovascular Science in Edinburgh and demonstrated a novel role for the transmembrane exporter ABCC1 in regulating adipose tissue glucocorticoid exposure. In 2018, I was awarded a BHF Basic Science Intermediate Research Fellowship to establish my own group in Edinburgh investigating the contribution of corticosteroid binding globulin (CBG) cleavage to adipose glucocorticoid delivery in obesity.

My research in a nutshell

Glucocorticoids are critical stress hormones that regulate a number of physiological processes including fuel metabolism and immune modulation. Conditions of overt glucocorticoid excess such as Cushing’s disease or chronic glucocorticoid treatment are associated with significant cardiometabolic abnormalities, including obesity, hyperglycemia, and hypertension. Indeed, while glucocorticoid treatment is a cornerstone in the management of many inflammatory diseases, and glucocorticoid replacement is essential for survival in patients with various forms of adrenal insufficiency, cardiovascular disease risk is increased 6-fold in people exposed to long-term supraphysiological doses of glucocorticoids. Notably, this association is more pronounced in women, highlighting sexually dimorphic responses to glucocorticoid therapy. 

Obesity, as a key driver of cardiovascular risk, is associated with complex glucocorticoid dysregulation, the direction of causality and the pathophysiological consequences of which are unknown. My lab addresses the hypothesis that obesity-induced glucocorticoid dysregulation is a key component in the development of these significant co-morbidities. Similarly, cardiovascular risk is increased in those subjects exposed to glucocorticoid excess. My lab’s discovery of mechanisms which confer tissue-specific control of glucocorticoid action independently of circulating levels provide the basis for a paradigm shift in the understanding of glucocorticoid biology, and uniquely position us to determine the impact of these mechanisms on co-morbidities associated with obesity, as well as on glucocorticoid-induced cardiovascular risk.

Education/Academic qualification

Postgraduate Certificate in Academic Practice, Postgraduate Certificate in Academic Practice , University of Edinburgh

Award Date: 28 Nov 2019

Diabetes and Endocrinology, Doctor of Philosophy (PhD), Interactions between glucocorticoid metabolism and inflammation in obesity, University of Edinburgh

Sept 2007Sept 2010

Award Date: 10 May 2011

Immunology, Bachelor of Science, University of Edinburgh

Sept 2002Jul 2006

Award Date: 20 Jul 2007

Fingerprint

Dive into the research topics where Mark Nixon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or